Naturland Holding ZrtBUD:NATURLAND 61 Net Margin % is 22.27% as of Jun. 2025, which is 5% below its 10-year median of 23.36. GuruFocus rates BUD:NATURLAND with a GF Score™ of 61/100 and a GF Value™ of Ft2,879.22 (Fairly Valued). The stock has 6 warning signs investors should review. Among 956 Drug Manufacturers companies, Naturland Holding Zrt ranks better than 90.48% on this metric.
The historical rank and industry rank for Naturland Holding Zrt's Net Margin % or its related term are showing as below:
BUD:NATURLAND'
s Net Margin % Range Over the Past 10 Years
Min: 20.59 Med: 23.36 Max: 87.1
Current: 23.15
BUD:NATURLAND's Net Margin % is ranked better than 90.48% of 956
companies
in the Drug Manufacturers industry
Industry Median: 5.56
vs BUD:NATURLAND: 23.15
Naturland Holding Zrt (BUD:NATURLAND) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Naturland Holding Zrt Net Margin % Related Terms
Naturland Holding Zrt Net Margin % Historical Data
* Premium members only.
The historical data trend for Naturland Holding Zrt's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BUD:NATURLAND vs ZTS, UTHR, VTRS: Net Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Naturland Holding Zrt's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Naturland Holding Zrt Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Naturland Holding Zrt's Net Margin % distribution charts can be found below:
* The bar in red indicates where Naturland Holding Zrt's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Naturland Holding Zrt (BUD:NATURLAND) has a Net Margin % of 22.27% as of Jun. 2025. Net margin is the ratio of total net income to net sales. View historical data on Naturland Holding Zrt and its competitors. This is near median its historical median of 23.36. Over the past decade, Naturland Holding Zrt's Net Margin % has ranged from 20.59 to 87.10. According to the industry distribution chart, Naturland Holding Zrt ranks #91 out of 956 companies in the Drug Manufacturers industry, placing it in the top 9.5%.
Is Naturland Holding Zrt's Net Margin % too high?
Naturland Holding Zrt's current Net Margin % of 22.27% is near median its 10-year median of 23.36. Over the past 10 years, this metric has ranged from a low of 20.59 to a high of 87.10. The Drug Manufacturers industry median Net Margin % is 5.56. Naturland Holding Zrt's value of 22.27% is 300.5% above this industry median. Based on the distribution chart, Naturland Holding Zrt ranks #91 out of 956 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Naturland Holding Zrt has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Naturland Holding Zrt's Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Naturland Holding Zrt ranks #91 out of 956 companies for Net Margin %. This places Naturland Holding Zrt in the top 10% of its industry — outperforming the majority of peers. The industry median Net Margin % is 5.56. Naturland Holding Zrt's value of 22.27% is 300.5% above this benchmark. Historically, Naturland Holding Zrt's own Net Margin % has ranged from 20.59 to 87.10 over the past decade. While the company's 10-year median is 23.36 vs. the industry median of 5.56, Naturland Holding Zrt has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Naturland Holding Zrt's current Net Margin % of 22.27% is 300.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Naturland Holding Zrt and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Naturland Holding Zrt's current Net Margin % is 22.27%, which is near median its own 10-year median of 23.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturland Holding Zrt stock overvalued right now?
Based on GuruFocus' analysis, Naturland Holding Zrt (BUD:NATURLAND) is currently considered Fairly Valued. The stock's GF Value™ is Ft2,879.22, compared to a current price of Ft2,820.00 — trading 2.1% below its estimated fair value. The current Net Margin % is 22.27%, which is near median its 10-year median of 23.36 and 300.5% above the Drug Manufacturers industry median of 5.56. Naturland Holding Zrt's overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Naturland Holding Zrt (BUD:NATURLAND), the current Net Margin % is 22.27% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Naturland Holding Zrt (BUD:NATURLAND) Overvalued in 2026?
Based on GuruFocus' analysis, Naturland Holding Zrt stock appears to be undervalued.
The current stock price of Ft2,820.00 is trading 2.1% below its estimated GF Value™ of Ft2,879.22.
GuruFocus considers Naturland Holding Zrt to be Fairly Valued.
Key valuation signals for BUD:NATURLAND:
Net Margin %: 22.27% (near median its 10-year median of 23.36)
GF Value™: Ft2,879.22 vs. price of Ft2,820.00 (2.1% below fair value)
Industry Position: 300.5% above the Drug Manufacturers median (#91 of 956)
No single metric tells the full story. See the BUD:NATURLAND stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Naturland Holding Zrt thro9ugh its subsidiaries engage in the production of pharmaceutical products. It engages in the development, production, and wholesale of dietary supplements and cosmetics, herbal medicine, teas, and essential oils. The firm offers tablets, suppositories, ointments, and ophthalmic base solutions.
61GF Score
Get the complete analysis for BUD:NATURLAND
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUD:NATURLAND has been successfully added to your 
